Borderline Rejection

Borderline Rejection is a histopathological diagnostic category in transplant pathology that represents a minimal form of T-cell–mediated rejection, distinguished by the presence of subtle tubulitis and interstitial inflammation insufficient to meet definitive criteria for acute rejection.

69

Publications

3.9K

Citations

467

Authors

167

Institutions

Publications per year

2017–2026

25

Variants

Borderline T-cell–mediated Rejection

Authors

467

  1. MM
    Michael Mengel

    Medizinische Hochschule Hannover, Germany

    6 publications · 1.3K citations

    6

    h-index

  2. PR
    Parmjeet Randhawa

    University of Pittsburgh, United States

    5 publications · 902 citations

    5

    h-index

  3. MN
    Maarten Naesens

    KU Leuven, Belgium

    4 publications · 1K citations

    4

    h-index

  4. BS
    B. Sis

    University of Alberta, Canada

    4 publications · 439 citations

    4

    h-index

  5. BJ
    Brian J. Nankivell

    Westmead Hospital, Australia

    4 publications · 969 citations

    4

    h-index

1–5 of 467

Venues

  1. American Journal of Transplantation

    15 publications · 2K citations

    15

    h-index

  2. Transplantation

    13 publications · 712 citations

    13

    h-index

  3. Clinical Transplantation

    8 publications · 177 citations

    8

    h-index

  4. Transplant International

    5 publications · 134 citations

    5

    h-index

  5. Transplantation Direct

    2 publications · 42 citations

    2

    h-index

1–5